Scynexis (SCYX) FCF Margin Growth (3y) (2016 - 2026)
Powered by 
Analysis
Scynexis (SCYX) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | -2,024.00 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 1,067.00 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | -1,272.00 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | -2,228.00 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -5,426.00 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 4,612.00 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -203.00 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 14,060.00 |
| 10 | Scynexis | 52.73 Mn | -61.96 Mn | - | -639,064.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -639,064.00 |
| Dec 31, 2025 | 159,514.00 |
| Sep 30, 2025 | -116,638.00 |
| Jun 30, 2025 | 85,497.00 |
| Mar 31, 2025 | -62,067.00 |
| Dec 31, 2024 | 318,062.00 |
| Sep 30, 2024 | 337,579.00 |
| Mar 31, 2024 | -28,407.00 |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 787,381.00 |
| Dec 31, 2021 | 540,849.00 |
| Sep 30, 2021 | 645,105.00 |
| Mar 31, 2021 | 1.29 Mn |
| Jun 30, 2019 | 43,791.00 |
| Mar 31, 2019 | 386,406.00 |
| Dec 31, 2018 | -19,062.00 |
| Sep 30, 2018 | -70,469.00 |
| Jun 30, 2018 | 51,562.00 |
| Mar 31, 2018 | -559,935.00 |
| Dec 31, 2017 | -789,086.00 |